IL-2/LAK therapy for refractory acute monoblastic leukemia relapsing after unrelated allogeneic bone marrow transplantation
Hitomi Nagayama, S Asano(Hiroshima University), Kenji Ikebuchi(Hokkaido University Hospital), Satoshi Takahashi(Sapporo Medical University), Takashi Takahashi(Kitasato University), Kenzaburo Tani(Tokyo Medical University), Kentaro Ogami(The University of Tokyo), Arinobu Tojo(Tokyo Medical and Dental University)
Cited by 14
Related Papers
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
|Journal of Clinical Oncology|2009|516
Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue
|Blood|1977|458